![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » UK’s NICE Seeks Feedback on Use of Real-World Data
UK’s NICE Seeks Feedback on Use of Real-World Data
![NICE-logo.gif](https://www.fdanews.com/ext/resources/test/Drug-Images/NICE-logo.gif?t=1604717099&width=430)
July 10, 2019
The U.K.’s National Institute for Health and Care Excellence wants to make more use of real-world data and has released a consultation document for comment.
NICE is considering using data from audits of procedures, registries that collect data on how particular treatments are used, surveys of patients using services, and data on national trends, such as the number of people who have a condition.
“If given the go-ahead, NICE believes it will help us to further improve our guidance, update it more quickly, and have a better understanding of the impact it has for people accessing health and social care services,” the institute said.
The consultation is open until Sept. 13, 2019.
Upcoming Events
-
21Oct